Jordan R Covvey1, Khalid M Kamal2, Erin E Gorse2, Zumi Mehta2, Trupti Dhumal2, Elham Heidari2,3, Deepika Rao2,4, Christopher Zacker5. 1. Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA. covveyj@duq.edu. 2. Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA. 3. Division of Health Outcomes and Pharmacy Practice, The University of Texas at Austin College of Pharmacy, 2409 University Ave Stop A1900, Austin, TX, 78712, USA. 4. Division of Social and Administrative Sciences, University of Wisconsin-Madison School of Pharmacy, 777 Highland Ave, Madison, WI, 53706, USA. 5. Health Economics and Outcomes Research, Novartis Oncology, 1 Health Plaza, East Hanover, NJ, 07936, USA.
Abstract
PURPOSE: Shared decision-making (SDM) is a strategy to facilitate patient-centered care and is increasingly important in oncology, where patients are faced with complicated treatment decisions that require them to weigh efficacy and safety, quality of life, and cost. Understanding the contributors to the use of SDM may provide insight to its further implementation. Therefore, the objective of the study was to examine the patient-related barriers/facilitators to SDM in oncology care. METHODS: A systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was executed. A search strategy composed of cancer, decision-making, and patient-centered terms was conducted utilizing PubMed, EBSCO MEDLINE, Scopus, CINAHL, and the Cochrane Library databases between January 2007 and November 2017. Full-text, US-based, English language articles describing the patient perspective of SDM in oncology care were included. Relevant data from articles were reviewed in a qualitative synthesis. RESULTS: From 3435 potential citations, a total of 35 articles were included. The most common cancers studied were breast (n = 22; 62.9%) and prostate (n = 9; 25.7%). The identified themes for barriers to SDM were uncertainty in the treatment decision, concern regarding adverse effects, and poor physician communication. Themes for facilitators for SDM included physician consideration of patient preferences, positive physician actions and behaviors, and use or encouragement of support systems. CONCLUSION: As SDM gains use within oncology practice, understanding key influences will allow for more effective implementation of strategies to increase patient engagement and improve care and value in the treatment process.
PURPOSE: Shared decision-making (SDM) is a strategy to facilitate patient-centered care and is increasingly important in oncology, where patients are faced with complicated treatment decisions that require them to weigh efficacy and safety, quality of life, and cost. Understanding the contributors to the use of SDM may provide insight to its further implementation. Therefore, the objective of the study was to examine the patient-related barriers/facilitators to SDM in oncology care. METHODS: A systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was executed. A search strategy composed of cancer, decision-making, and patient-centered terms was conducted utilizing PubMed, EBSCO MEDLINE, Scopus, CINAHL, and the Cochrane Library databases between January 2007 and November 2017. Full-text, US-based, English language articles describing the patient perspective of SDM in oncology care were included. Relevant data from articles were reviewed in a qualitative synthesis. RESULTS: From 3435 potential citations, a total of 35 articles were included. The most common cancers studied were breast (n = 22; 62.9%) and prostate (n = 9; 25.7%). The identified themes for barriers to SDM were uncertainty in the treatment decision, concern regarding adverse effects, and poor physician communication. Themes for facilitators for SDM included physician consideration of patient preferences, positive physician actions and behaviors, and use or encouragement of support systems. CONCLUSION: As SDM gains use within oncology practice, understanding key influences will allow for more effective implementation of strategies to increase patient engagement and improve care and value in the treatment process.
Entities:
Keywords:
Communication barriers; Neoplasms; Patient participation; Patient-centered care
Authors: Patricia J Hollen; Richard J Gralla; Ryan D Gentzler; Richard D Hall; Bethany Coyne; Haiying Cheng; Balazs Halmos; Jane Gildersleeve; Claudia Calderon; Ivora Hinton; Geoffrey Weiss; Jeffrey Crawford; Jane Cerise; Martin Lesser Journal: Oncologist Date: 2020-11-10
Authors: Emma C Lape; Jeffrey N Katz; Justin A Blucher; Angela T Chen; Genevieve S Silva; Joseph H Schwab; Tracy A Balboni; Elena Losina; Andrew J Schoenfeld Journal: Spine J Date: 2019-12-30 Impact factor: 4.166
Authors: Rachel S Hianik; Gavin P Campbell; Eli Abernethy; Colleen Lewis; Christina S Wu; Mehmet Akce; Margie D Dixon; Walid L Shaib; Rebecca D Pentz Journal: JCO Oncol Pract Date: 2020-05-19
Authors: Milou Steenbergen; Jolanda de Vries; Rita Arts; Laurens V Beerepoot; Marjan J Traa Journal: Support Care Cancer Date: 2022-01-18 Impact factor: 3.603
Authors: Lisa P Spees; Megan C Roberts; Andrew N Freedman; Eboneé N Butler; William M P Klein; Irene Prabhu Das; Janet S de Moor Journal: Patient Educ Couns Date: 2020-03-03